Leitlinie „Behandlung der Akne“ - AWMF

013/017 - Behandlung der Akne aktueller Stand: 02/2010
korrigierte Fassung: 10/2011
36. Stewart ME, Grahek MO, Cambier LS, Wertz PW, Downing DT. Dilutional effect of
increased sebaceous gland activity on the proportion of linoleic acid in sebaceous wax
esters and in epidermal acylceramides. J Invest Dermatol. 1986; 87: 733-6.
37. Pochi PE, Strauss JS. Sebaceous gland response in man to the administration of
testosterone, delta-4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol.
1969; 52: 32-6.
38. Gollnick HP, Zouboulis CC, Akamatsu H, Kurokawa I, Schulte A. Pathogenesis and
pathogenesis related treatment of acne. J Dermatol. 1991; 18: 489-99.
39. Chen W, Yang CC, Liao CY, Hung CL, Tsai SJ, Chen KF, Sheu HM, Zouboulis CC.
Expression of sex-determining genes in human sebaceous glands and their possible
role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2006; 20: 846-52.
40. Cunliffe W, Forster R. Androgen control of the pilosebaceous duct? Br J Dermatol.
1987; 116: 449.
41. Zouboulis CC. The sebaceous gland in adolescent age. Eur J Ped Dermatol. 2008; 18:
150-54.
42. Thiboutot D, Knaggs H, Gilliland K, Lin G. Activity of 5-alpha-reductase and 17-
beta-hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and
without acne vulgaris. Dermatology. 1998; 196: 38-42.
43. Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J. Acne
vulgaris in premenarchal girls. An early sign of puberty associated with rising levels
of dehydroepiandrosterone. Arch Dermatol. 1994; 130: 308-14.
44. Stewart ME, Downing DT, Cook JS, Hansen JR, Strauss JS. Sebaceous gland activity
and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol.
1992; 128: 1345-8.
45. Marynick SP, Chakmakjian ZH, McCaffree DL, Herndon JH, Jr. Androgen excess in
cystic acne. N Engl J Med. 1983; 308: 981-6.
46. Schmidt JB, Spona J, Huber J. Androgen receptor in hirsutism and acne. Gynecol
Obstet Invest. 1986; 22: 206-11.
47. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S. Activity of the type 1 5
alpha-reductase exhibits regional differences in isolated sebaceous glands and whole
skin. J Invest Dermatol. 1995; 105: 209-14.
48. Zouboulis CC. Therapie der Akne mit Antiandrogenen - Eine evidenzbasierte
Übersicht. J Dtsch Dermatol Ges. 2003; 1: 535-46.
49. Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P. The androgen
control of sebum production. Studies of subjects with dihydrotestosterone deficiency
and complete androgen insensitivity. J Clin Endocrinol Metab. 1993; 76: 524-8.
50. Rosenfield RL, Deplewski D, Kentsis A, Ciletti N. Mechanisms of androgen induction
of sebocyte differentiation. Dermatology. 1998; 196: 43-6.
51. Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5alphadihydrotestosterone
and synthesis of sebaceous lipids is regulated by the peroxisome
proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol.
2007; 156: 428-32.
Seite 108 von 136